News Focus
News Focus
Replies to #87523 on Biotech Values
icon url

genisi

12/15/09 10:36 AM

#87528 RE: tony111 #87523

Efficacy is more like MTX but I think the higher infection and discontinuation seen with apremilast in this 16 weeks trial is the bigger problem as this should be worse over longer period of use.